Cargando…

Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2‐dependent mechanism

BACKGROUND: N (6)‐methyladenosine (m6A) is of great importance in renal physiology and disease progression, but its function and mechanism in renal fibrosis remain to be comprehensively and extensively explored. Hence, this study will explore the function and potential mechanism of critical regulato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Wei‐Jian, Zhou, Hong, Lu, Hao, Ma, Nan‐Nan, Hou, Bing‐Bing, Li, Wei, Kong, Fan‐Xu, Yu, Ju‐Tao, Hou, Rui, Jin, Juan, Wen, Jia‐Gen, Zhang, Tao, Meng, Xiao‐Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400756/ https://www.ncbi.nlm.nih.gov/pubmed/37537731 http://dx.doi.org/10.1002/ctm2.1359

Ejemplares similares

METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3
por: Yi, Jianmei, et al.
Publicado: (2023)

METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner
por: Lu, Jiawei, et al.
Publicado: (2023)

METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification
por: Guo, Zhenyun, et al.
Publicado: (2022)

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer
por: Wan, Weijun, et al.
Publicado: (2022)

EVL regulates VEGF receptor‐2 internalization and signaling in developmental angiogenesis
por: Zink, Joana, et al.
Publicado: (2021)

METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma
por: Li, Ting, et al.
Publicado: (2019)

Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1
por: Huang, Chaoqing, et al.
Publicado: (2022)

METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner
por: Liang, Jianfeng, et al.
Publicado: (2023)

Splenectomy Combined with Endoscopic Variceal Ligation (EVL) versus EVL Alone for Secondary Prophylaxis of Variceal Bleeding in Hepatosplenic Schistosomiasis: A Retrospective Case–Control Study
por: Rakotomalala, Jolivet Auguste, et al.
Publicado: (2022)

Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway
por: Mao, Yan, et al.
Publicado: (2023)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

FLOT1, stabilized by WTAP/IGF2BP2 mediated N6-methyladenosine modification, predicts poor prognosis and promotes growth and invasion in gliomas
por: Song, Tao, et al.
Publicado: (2023)

METTL3-Modulated circUHRF2 Promotes Colorectal Cancer Stemness and Metastasis through Increasing DDX27 mRNA Stability by Recruiting IGF2BP1
por: Chen, Miao, et al.
Publicado: (2023)

Oncogenic Role of Long Noncoding RNAMALAT1 in Thyroid Cancer Progression through Regulation of the miR-204/IGF2BP2/m6A-MYC Signaling
por: Ye, Mao, et al.
Publicado: (2020)

IGF2BP2‑dependent STIM1 inhibition protects against LPS‑induced pneumonia in vitro by alleviating endoplasmic reticulum stress and the inflammatory response
por: Zhou, Wei, et al.
Publicado: (2023)

Single-stranded DNA catenation mediated by human EVL and a type I topoisomerase
por: Takaku, Motoki, et al.
Publicado: (2010)

CRMP-1 enhances EVL-mediated actin elongation to build lamellipodia and the actin cortex
por: Yu-Kemp, Hui-Chia, et al.
Publicado: (2017)

Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2021)

IGF2BP2 acts as a m(6)A modification regulator in laryngeal squamous cell carcinoma through facilitating CDK6 mRNA stabilization
por: Tang, Xiaojun, et al.
Publicado: (2023)

IGF2BP2-meidated m(6)A modification of CSF2 reprograms MSC to promote gastric cancer progression
por: Ji, Runbi, et al.
Publicado: (2023)

IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism
por: Cui, Jie, et al.
Publicado: (2021)

N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1
por: Dong, Guo, et al.
Publicado: (2021)

RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA
por: Fan, Jin, et al.
Publicado: (2023)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

N(6)-methyladenosine (m(6)A) methyltransferase METTL3 regulates sepsis-induced myocardial injury through IGF2BP1/HDAC4 dependent manner
por: Shen, Hao, et al.
Publicado: (2022)

IGF2BP2 and obesity interaction analysis for type 2 diabetes mellitus in Chinese Han population
por: Wu, Hui-Hui, et al.
Publicado: (2014)

METTL3‐mediated N6‐methyladenosine exacerbates ferroptosis via m6A‐IGF2BP2‐dependent mitochondrial metabolic reprogramming in sepsis‐induced acute lung injury
por: Zhang, Hao, et al.
Publicado: (2023)

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

m(6)A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis
por: Wei, Huamei, et al.
Publicado: (2023)

EVL is a novel focal adhesion protein involved in the regulation of cytoskeletal dynamics and vascular permeability
por: Mascarenhas, Joseph B., et al.
Publicado: (2021)

Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

EVL and MIM/MTSS1 regulate actin cytoskeletal remodeling to promote dendritic filopodia in neurons
por: Parker, Sara S., et al.
Publicado: (2023)

The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability
por: Zhang, Nan, et al.
Publicado: (2022)

Role of IGF2BP3 in trophoblast cell invasion and migration
por: Li, W, et al.
Publicado: (2014)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification
por: Shi, Wenjing, et al.
Publicado: (2022)

LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
por: Hou, Pingfu, et al.
Publicado: (2021)

HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification
por: Wang, Jiayu, et al.
Publicado: (2023)

Pharmacological and Genetic Inhibition of HDAC4 Alleviates Renal Injury and Fibrosis in Mice
por: Shen, Fengchen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6oe4aemcokm3gc2904ah7788f3